Skip to main content
. 2015 Nov 30;2016:7057894. doi: 10.1155/2016/7057894

Figure 10.

Figure 10

The transwell assay of Egr1-silenced EPCs. The increased migratory capacity of EPCs by DHT treatment was also blocked by Egr1-siRNA transfection. (a) Transwell migration assay was employed to examine the migration ability of DHT-treated EPCs after transfection of Egr1-siRNA or control. (b) The migrating EPCs were counted and averaged at high power field. All assays were triplicated and demonstrated similar results. Data are presented in mean ± SD format. ∗∗ P < 0.01 versus control group, ∗∗∗ P < 0.001 versus control group.